NCT01495858 - Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain | Biotech Hunter

Enrollment

267

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Pain, Postoperative

Interventions

DRUG

Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111)

Participants received one tablet of Naproxen Sodium 220 mg / Diphenhydramine hydrochloride (DPH) 25 mg and one tablet of Naproxen Sodium 220 mg, single dose, orally.

DRUG

Naproxen Sodium 440 mg (BAYH6689)

Participants received two tablets of Naproxen Sodium 220 mg, single dose, orally.

DRUG

DPH 50 mg

Participants received two tablets of Diphenhydramine hydrochloride (DPH) 25 mg, single dose, orally.

Trial Locations (2)

78744

Austin

84106

Salt Lake City